“GENOM” Medical Company provides (offers) services for the treatment of somatic diseases using modern cell therapy technologies. Our strategy includes a comprehensive treatment program with the participation of qualified physicians with an individual approach to each clinical case. At the same time, the laboratory sector of “GENOM” LLC interacts with specialized clinical departments of various profiles.
Depending on the type of pathology detected, the patient is referred for consultation to a specialist of the partner clinic. Subsequently, the patient is examined and a treatment plan is drawn up.
Algorithm of examination of the patient before the course of cell therapy:
-Objective examination and history taking
-General blood test
-General analysis of urine
-Developed biochemical analysis of blood
-Determination of blood group, Rh factor
-Coagulogram
-Women’s cancer panel (definition of tumor markers in women)
-Oncological male panel (definition of tumor markers in men)
-Ultrasound of the abdominal cavity and pelvic organs
-Additional laboratory and instrumental examinations
We offer an individual approach when choosing a biotechnology protocol for scaling your stem and somatic cells, taking into account all the characteristics of the primary cell material. We screen cells in the process of cultivation in order to optimize their expansion. Achieving a therapeutic effect is our priority.
The arsenal of therapeutic techniques includes the use of cellular drugs with different sources of origin:
-Autological mesenchymal stromal stem cells of adipose tissue
-Autological dermal fibroblasts
-Allogeneic or autologous hematopoietic cells of umbilical cord blood
-Allogeneic neonatal mesenchymal stem cells (perivascular space of the umbilical cord, placenta, amniotic epithelium, a stage before clinical and clinical trials).
Photo gallery
Video gallery
Packages of medical services:
Program of regenerative therapy with allogeneic mesenchymal stem cells (source of origin: umbilical cord – perivascular space, amniotic membrane):
1) Premium package. Therapy for allogeneic MSCs (90 million). Three-stage intravenous insertion program. (single dose of 30 million, repeated insertion – every 15 days). – 90,000 UAH;
2) Premium MAX package. Therapy with allogeneic MSCs (210 million). Program of seven-time intravenous insertion. (single dose of 30 million, repeated insertion – every 15 days). – 145,000 UAH;
3) Standard package. Therapy with allogeneic MSCs (60 million). Three-stage intravenous insertion program. (single dose of 20 million, repeated insertion – every 15 days). – 56,000 UAH;
4) Local therapy package. Local therapy with allogeneic MSCs (20 million) – 31,000 UAH.
Program of regenerative therapy with autologous mesenchymal stem cells (MSC) of adipose tissue:
5) Premium package. Therapy of autologous MSCs of adipose tissue (90 million). Three-stage intravenous insertion program. (single dose of 30 million, repeated insertion – every 7-10 days). – 45,000 UAH;
6) Premium MAX package. Therapy of autologous MSCs of adipose tissue (210 million). Seven intravenous insertion program. (single dose of 30 million, repeated insertion – every 7-10 days). – 85,000 UAH;
7) Standard package. Therapy of autologous MSCs of adipose tissue (60 million). Three-stage intravenous insertion program. (single dose of 20 million, repeated insertion – every 7-10 days). – 30,000 UAH;
8) Local therapy package. Local therapy with autologous MSCs of adipose tissue (30 million) – 15,000 UAH.
Neofibrolifting
– Revitalization of the skin by autologous dermal fibroblasts
1) Premium package. SPRS – therapy (Service for Personal Regeneration of Skin) with autologous dermal fibroblasts (80 million) – 15,000 UAH;
2) Standard package. SPRS – therapy with autologous dermal fibroblasts (40 million) – 10,000 UAH;
3) Package “local therapy”. SPRS – therapy with autologous dermal fibroblasts (20 million) – 7,000 UAH.